flow trial semaglutide kidney outcomes hazard ratio 0.76 nejm 2024 Semaglutides Are Poised to Remake Chronic Disease Care Contrary to popular belief: GLP-1

Most GLP-1 users accidentally undereat protein by 40% or more because appetite suppression works so effectively, accelerating muscle loss that undermines long-term metabolic health and creating plateaus that feel like treatment failure

Modern peptide synthesis is dominated by solid-phase peptide synthesis (SPPS), which allows for the creation of a highly pure synthetic peptide, pioneered by Bruce Merrifield and refined over decades

One way they achieve this is by slowing gastric emptying, meaning food stays in the stomach longer, leading to prolonged feelings of fullness and reduced calorie intake

Growth hormone secretagogues: GHRP-2 , GHRP-6 , Hexarelin , MK-677 availability varies